Incomplete harms reporting in systematic reviews of direct oral factor Xa inhibitors
Open Access
- 17 October 2025
- journal article
- review article
- Published by American Society of Hematology in Blood Advances
- Vol. 9 (20) , 5289-5292
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- US Emergency Department Visits Attributed to Medication Harms, 2017-2019JAMA, 2021
- Epidemiology of Atrial Fibrillation in the 21st CenturyCirculation Research, 2020
- Examining overlap of included studies in meta‐reviews: Guidance for using the corrected covered area indexResearch Synthesis Methods, 2019
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or bothBMJ, 2017
- PRISMA harms checklist: improving harms reporting in systematic reviewsBMJ, 2016
- Side effects are incompletely reported among systematic reviews in gastroenterologyJournal of Clinical Epidemiology, 2015
- Oral Direct Factor Xa InhibitorsCirculation Research, 2012
- Systematic reviews of adverse effects: framework for a structured approachBMC Medical Research Methodology, 2007
- Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT StatementAnnals of Internal Medicine, 2004